Background The coronavirus disease 2019 (COVID-19) has swept the globe and is causing
significant morbidity and mortality. Given that the virus is transmitted via droplets, open …

Background National targets for timely diagnosis and management of a potential cancer are
driven in part by the perceived risk of disease progression during avoidable delays …

Timely care is an important dimension of health care quality, but the impact of delays in care
on lung cancer outcomes is unclear. Quantifying the impact of delays in cancer treatment on …

This European Respiratory Society guideline is dedicated to the provision of good quality
recommendations in lung cancer care. All the clinical recommendations contained were …

Background Optimal time to treatment for early-stage lung cancer is uncertain. We examined
causes of delays in care for Veterans who presented with early-stage non–small cell lung …

Over half of patients with lung cancer are diagnosed at a stage when curative treatment is
not possible, suggesting an earlier diagnosis could improve outcomes. This comprehensive …

Background In stage IIIA non‐small cell lung cancer (NSCLC), surgery plays a role in terms
of multimodal treatment. Surgery rates have increased in recent years, mainly due to the …

Abstract Objectives Important differences in Stage I non–small‐cell lung cancer (NSCLC)
are related to the delay in the diagnosis to the treatment, hospitals' specialised status …

Background Cervical cancer is a growing public health problem globally. Despite the
availability of management options, the progression of the disease as a function of waiting …

The drive to increase lung cancer resection rates continues and with it, the need to reduce
the perioperative risks and improve post-operative quality of life for an increasingly high-risk …